Tyler MA - Search Results

1

Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.

Ulasov IV, Tyler MA, Han Y, Glasgow JN, Lesniak MS. Ulasov IV, et al. Among authors: tyler ma. Hum Gene Ther. 2007 Feb;18(2):118-29. doi: 10.1089/hum.2006.146. Hum Gene Ther. 2007. PMID: 17328684

2

An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.

Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS. Ulasov IV, et al. Int J Oncol. 2007 Nov;31(5):1177-85. Int J Oncol. 2007. PMID: 17912445

3

CD46 represents a target for adenoviral gene therapy of malignant glioma.

Ulasov IV, Tyler MA, Zheng S, Han Y, Lesniak MS. Ulasov IV, et al. Among authors: tyler ma. Hum Gene Ther. 2006 May;17(5):556-64. doi: 10.1089/hum.2006.17.556. Hum Gene Ther. 2006. PMID: 16716112

4

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.

Tyler MA, Ulasov IV, Borovjagin A, Sonabend AM, Khramtsov A, Han Y, Dent P, Fisher PB, Curiel DT, Lesniak MS. Tyler MA, et al. Mol Cancer Ther. 2006 Sep;5(9):2408-16. doi: 10.1158/1535-7163.MCT-06-0187. Mol Cancer Ther. 2006. PMID: 16985075

5

Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.

Zheng S, Ulasov IV, Han Y, Tyler MA, Zhu ZB, Lesniak MS. Zheng S, et al. Among authors: tyler ma. J Gene Med. 2007 Mar;9(3):151-60. doi: 10.1002/jgm.1008. J Gene Med. 2007. PMID: 17351980

6

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.

Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, Curiel DT, Lesniak MS. Ulasov IV, et al. Among authors: tyler ma. Hum Gene Ther. 2007 Jul;18(7):589-602. doi: 10.1089/hum.2007.002. Hum Gene Ther. 2007. PMID: 17630837

7

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.

Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS. Sonabend AM, et al. Among authors: tyler ma. Stem Cells. 2008 Mar;26(3):831-41. doi: 10.1634/stemcells.2007-0758. Epub 2008 Jan 10. Stem Cells. 2008. PMID: 18192232

8

Vector therapies for malignant glioma: shifting the clinical paradigm.

Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS. Tyler MA, et al. Expert Opin Drug Deliv. 2008 Apr;5(4):445-58. doi: 10.1517/17425247.5.4.445. Expert Opin Drug Deliv. 2008. PMID: 18426385 Review.

9

Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy.

Ulasov IV, Tyler MA, Rivera AA, Nettlebeck DM, Douglas JT, Lesniak MS. Ulasov IV, et al. Among authors: tyler ma. J Med Virol. 2008 Sep;80(9):1595-603. doi: 10.1002/jmv.21264. J Med Virol. 2008. PMID: 18649343 Free PMC article.

10

Targeted therapies for malignant glioma: progress and potential.

Mercer RW, Tyler MA, Ulasov IV, Lesniak MS. Mercer RW, et al. Among authors: tyler ma. BioDrugs. 2009;23(1):25-35. doi: 10.2165/00063030-200923010-00003. BioDrugs. 2009. PMID: 19344189 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters